SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-050505
Filing Date
2018-08-08
Accepted
2018-08-08 16:13:53
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14124_110q.htm 10-Q 958908
2 EX-31.1 a18-14124_1ex31d1.htm EX-31.1 9731
3 EX-31.2 a18-14124_1ex31d2.htm EX-31.2 9704
4 EX-32.1 a18-14124_1ex32d1.htm EX-32.1 5898
5 EX-32.2 a18-14124_1ex32d2.htm EX-32.2 5909
  Complete submission text file 0001104659-18-050505.txt   3613601

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT btai-20180630.xml EX-101.INS 649308
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT btai-20180630.xsd EX-101.SCH 34510
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT btai-20180630_cal.xml EX-101.CAL 26605
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT btai-20180630_lab.xml EX-101.LAB 272123
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT btai-20180630_pre.xml EX-101.PRE 209264
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT btai-20180630_def.xml EX-101.DEF 102128
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38410 | Film No.: 181001497
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences